{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T12:16:07Z","timestamp":1775996167558,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.08.015","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:18:09Z","timestamp":1597180689000},"page":"450-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood sampling"],"prefix":"10.1016","volume":"510","author":[{"given":"Matthias","family":"Gijsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willy E.","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Debaveye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.08.015_b0005","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2020.08.015_b0010","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.bbmt.2018.06.031","article-title":"Impact of the use and type of antibiotics on acute graft-versus-host disease","volume":"24","author":"Nishi","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.cca.2020.08.015_b0015","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation","volume":"23","author":"Weber","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.cca.2020.08.015_b0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrc.2018.10","article-title":"Gut microbiota injury in allogeneic haematopoietic stem cell transplantation","volume":"18","author":"Shono","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cca.2020.08.015_b0025","doi-asserted-by":"crossref","first-page":"339ra371","DOI":"10.1126\/scitranslmed.aaf2311","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2020.08.015_b0030","unstructured":"US National Library of Medicine. ClinicalTrials.gov, (2017). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03078010?term=NCT03078010&draw=2&rank=1."},{"key":"10.1016\/j.cca.2020.08.015_b0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1060028014564179","article-title":"Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review","volume":"49","author":"Burgess","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.cca.2020.08.015_b0040","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.43.10.2559","article-title":"Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing","volume":"43","author":"Lipman","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cca.2020.08.015_b0045","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/cc8941","article-title":"Prospective monitoring of cefepime in intensive care unit adult patients","volume":"14","author":"Chapuis","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2020.08.015_b0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2125.2010.03749.x","article-title":"Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths)","volume":"70","author":"Wright","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cca.2020.08.015_b0055","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1016\/j.ejim.2008.01.007","article-title":"Spurious toxic vancomycin levels","volume":"19","author":"Naschitz","year":"2008","journal-title":"Eur. J. Int. Med."},{"key":"10.1016\/j.cca.2020.08.015_b0060","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.pedn.2015.07.011","article-title":"A comparison of antibiotic serum concentrations drawn simultaneously from peripherally inserted central catheters and peripheral veins in children with respiratory infection","volume":"30","author":"Green","year":"2015","journal-title":"J. Pediatr. Nursing"},{"key":"10.1016\/j.cca.2020.08.015_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jspn.12006","article-title":"Comparison of central venous catheter and peripheral vein samples of antibiotics in children with cystic fibrosis","volume":"18","author":"Wilson","year":"2013","journal-title":"J. Spec. Pediatr. Nurs."},{"key":"10.1016\/j.cca.2020.08.015_b0070","doi-asserted-by":"crossref","first-page":"e12212","DOI":"10.1111\/jspn.12212","article-title":"Therapeutic antibiotic serum concentrations by two blood collection methods within the pediatric patient: A comparative effectiveness trial","volume":"23","author":"Lichliter","year":"2018","journal-title":"J. Spec. Pediatr. Nurs."},{"key":"10.1016\/j.cca.2020.08.015_b0075","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cca.2018.08.008","article-title":"Beta-lactam carryover in arterial and central venous catheters is negligible","volume":"486","author":"Marsh","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2020.08.015_b0080","first-page":"1","article-title":"Flushing and locking of venous catheters: available evidence and evidence deficit","author":"Goossens","year":"2015","journal-title":"Nurs. Res. Pract."},{"key":"10.1016\/j.cca.2020.08.015_b0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.cca.2020.08.015_b0090","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.theriogenology.2010.01.003","article-title":"Method agreement analysis: A review of correct methodology","volume":"73","author":"Watson","year":"2010","journal-title":"Theriogenology"},{"key":"10.1016\/j.cca.2020.08.015_b0095","unstructured":"G.B. McBride, A proposal for strength-of-agreement criteria for Lin's concordance correlation coefficient, 2005. Retrieved from https:\/\/www.medcalc.org\/download\/pdf\/McBride2005.pdf."},{"key":"10.1016\/j.cca.2020.08.015_b0100","unstructured":"Working Group for Preanalytical Phase (WG-PRE), of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM), (2017) Venous blood sampling guidelines. Retrieved from https:\/\/www.eflm.eu\/upload\/docs\/WG-PRE%20Venous%20blood%20sampling_for%20EFLM%20NSs.pdf."},{"key":"10.1016\/j.cca.2020.08.015_b0105","unstructured":"World Health Organization, Best Practices for Injections and Related Procedures Toolkit, 2010. Chapter 3. Retrieved from https:\/\/www.who.int\/infection-prevention\/publications\/best-practices_toolkit\/en\/."},{"key":"10.1016\/j.cca.2020.08.015_b0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cca.2020.08.015_b0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmi.2019.06.028","article-title":"Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study","volume":"26","author":"Boschung-Pasquier","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cca.2020.08.015_b0120","unstructured":"F. Kabi, Cefepime Fresenius Kabi 1g and 2g Powder for Injection. Retrieved from https:\/\/www.fresenius-kabi.com\/au\/documents\/Cefepime_Kabi_PI.pdf. Australian Product Information, 2019."},{"key":"10.1016\/j.cca.2020.08.015_b0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0142-9612(96)89770-5","article-title":"Uptake of drugs by catheters: the influence of the drug molecule on sorption by polyurethane catheters","volume":"17","author":"Smith","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.cca.2020.08.015_b0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2702.2012.04187.x","article-title":"Cyclosporine level: difference between blood samples collected through peripheral and central venous access: Cyclosporine level in blood samples collected","volume":"22","author":"Garbin","year":"2013","journal-title":"J Clin Nurs"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:59:47Z","timestamp":1757861987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120303971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"alternative-id":["S0009898120303971"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.015","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood sampling","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}